Overview
Cellbricks develops 3D tissue implants and organ-replacement technologies aimed at advancing regenerative medicine. Their products are intended for patients requiring organ replacement, surgical centers, and healthcare providers seeking alternatives to donor transplants. The company focuses on implantable tissue constructs designed to restore function and address organ failure. In March 2026 Silicon Roundabout backed an undisclosed financing reported as €10M (listed as $10M), representing the company's only disclosed round and bringing total raised to $10M. Cellbricks differentiates itself by concentrating on 3D tissue implants and organ-replacement solutions within the bioengineering and medical-device space.
Funding History
Silicon Roundabout backs Cellbricks’ €10M round to advance 3D tissue implants and organ replacement
Frequently Asked Questions
- How much has Cellbricks raised in total?
- Cellbricks has raised a total of $10M across 1 funding round.
- Who are Cellbricks's investors?
- Cellbricks's investors include Undisclosed.
- What does Cellbricks do?
- Cellbricks develops 3D tissue implants and organ-replacement technologies aimed at advancing regenerative medicine. Their products are intended for patients requiring organ replacement, surgical centers, and healthcare providers seeking alternatives to donor transplants. The company focuses on implantable tissue constructs designed to restore function and address organ failure. In March 2026 Silicon Roundabout backed an undisclosed financing reported as €10M (listed as $10M), representing the company's only disclosed round and bringing total raised to $10M. Cellbricks differentiates itself by concentrating on 3D tissue implants and organ-replacement solutions within the bioengineering and medical-device space.
- Where is Cellbricks headquartered?
- Cellbricks is headquartered in San Francisco, CA.
Investors
Related Insights
A comprehensive analysis of Hebbia's funding history, investors, competitive position, and growth trajectory in the Enterprise AI space.
An in-depth analysis of Lux Capital's AI investment portfolio, strategy, co-investors, and sector focus across 4 tracked deals.
A comprehensive analysis of Mind Robotics's funding history, investors, competitive position, and growth trajectory in the AI space.